Stocks
Enochian Biosciences, Inc.ENOB
NASDAQHealthcareBiotechnology$0.71+1.79%
Price as of · delayed, not real-time
Focused on developing innovative therapies for infectious diseases and cancer, this biotechnology company leverages its proprietary platform to advance novel treatments. Investors monitor its progress due to its pipeline targeting high unmet medical needs and potential for partnerships or acquisitions.
Market Cap: $45.4M52W Range: $0.39 – $2.99
Congressional Interest in Enochian Biosciences, Inc. (ENOB)
1 member of Congress has disclosed 2 trades in Enochian Biosciences, Inc. (ENOB), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading ENOB?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-11-08 | Christopher L. Jacobs | sell | $1K – $15K |
| 2022-07-18 | Christopher L. Jacobs | buy | $1K – $15K |